Rituximab and Combination Chemotherapy in Treating Patients With Primary Central Nervous System Lymphoma
Clinical trial NCT00335140 · TERMINATED
Trial details
- NCT number
- NCT00335140
- Sponsor
- Eastern Cooperative Oncology Group
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-08-23
- Primary completion
- 2015-07-01
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.